Can semaglutide make you feel sick — and what does the evidence say?

What the trial data tell us about sickness on semaglutide

The STEP 1 trial, which forms the basis for Wegovy's UK licence, gives the clearest picture we have. Roughly 44% of participants on semaglutide 2.4mg experienced nausea during the 68-week programme, while vomiting affected around 24% and diarrhoea around 30%. The rates sound high until you look at when the events happened: the vast majority were concentrated in the early weeks of treatment and after each dose step upward. By the time participants reached the maintenance dose and had been on it for several months, many reported little or no ongoing nausea.

The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, indigestion and stomach discomfort as common effects, common meaning more than one in ten people. That framing is worth holding onto: these are expected, documented effects that the medicine is known to produce, not signs that something has gone wrong.

One misconception that comes up often: some people assume feeling sick means the medicine is harming them, or that they should stop immediately. In most cases, early nausea reflects the way semaglutide slows gastric emptying and signals the brain's appetite centres, the same mechanism that helps reduce food intake. It tends to improve, not worsen, as weeks pass.

Why dose increases are when sickness tends to return

Semaglutide treatment in the UK starts at 0.25mg weekly, rising in steps over several months. Each increase can briefly reset the nausea clock. That is not unusual, the prescriber-guided titration schedule exists precisely to give the body time to adapt at each level before moving up.

If you are finding a particular dose difficult, that is a conversation to have with your prescriber before any adjustment, not something to manage alone. Practical steps people take when semaglutide causes persistent sickness include eating smaller portions, avoiding fatty or spicy food around injection day, and staying well hydrated. None of these replace clinical advice, but they reflect what tends to help most people through the early phase.

For practical strategies around nausea specifically, guidance on managing Wegovy-related nausea covers evidence-informed approaches worth discussing with your clinical team. The fatigue that some people report on semaglutide often travels alongside nausea in the first weeks, both are worth mentioning at your next review.

When sickness is a warning sign, not a side effect

Ordinary treatment nausea is unpleasant but not dangerous. There are, however, symptoms that should prompt urgent medical help rather than a wait-and-see approach.

In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines including semaglutide. The symptom to watch for is severe stomach pain that does not ease and that radiates toward the back, sometimes accompanied by vomiting but distinct from the queasy, unsettled feeling that most people experience after starting or increasing their dose. If that pattern appears, seek medical attention promptly rather than treating it as routine nausea.

Other symptoms worth taking seriously include signs of a significant allergic reaction, severe or persistent vomiting that prevents keeping fluids down, or any symptoms of pancreatitis. Suspected side effects can be reported at the MHRA's Yellow Card scheme, a resource available to patients as well as clinicians.

For a fuller picture of what to expect across the range of Wegovy's documented effects, the complete Wegovy side effects overview covers the full licensed profile. And if you are still deciding whether Wegovy is the right route for you, an overview of weight-loss treatment options lays out how the available medicines compare.

Starting semaglutide with the side-effect picture in mind

Feeling sick during the early weeks of semaglutide is genuinely common, the data are clear on that. It is also, for most people, temporary. What matters is that someone with clinical oversight knows what you are experiencing, can confirm the symptoms are expected, and can step in if anything looks different from the normal pattern.

At nume, every prescription is reviewed by a GPhC-registered Independent Prescriber before it is issued, and aftercare is available seven days a week so that questions about side effects reach a real clinician rather than a holding page. If you are considering starting treatment, a free consultation is the first step, no commitment, and the same-day clinical review means you get a clear answer quickly. You can also read why semaglutide produces nausea at a biological level if you'd like to understand the mechanism before your consultation.